177 related articles for article (PubMed ID: 15309201)
1. Leukocyte recruitment to atherosclerotic lesions.
Cybulsky MI; Won D; Haidari M
Can J Cardiol; 2004 Aug; 20 Suppl B():24B-28B. PubMed ID: 15309201
[TBL] [Abstract][Full Text] [Related]
2. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
[TBL] [Abstract][Full Text] [Related]
3. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
4. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
[TBL] [Abstract][Full Text] [Related]
6. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A.
Ostermann G; Fraemohs L; Baltus T; Schober A; Lietz M; Zernecke A; Liehn EA; Weber C
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):729-35. PubMed ID: 15681301
[TBL] [Abstract][Full Text] [Related]
7. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
8. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in the pathogenesis of vascular disease.
Charo IF; Taubman MB
Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
[TBL] [Abstract][Full Text] [Related]
10. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment.
He M; Horuk R; Bhatia M
Pancreas; 2007 Mar; 34(2):233-41. PubMed ID: 17312463
[TBL] [Abstract][Full Text] [Related]
11. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo.
Smith DF; Deem TL; Bruce AC; Reutershan J; Wu D; Ley K
J Leukoc Biol; 2006 Dec; 80(6):1491-9. PubMed ID: 16997858
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte adhesion in aorta and femoral artery in vivo is mediated by LFA-1.
Schramm R; Menger MD; Schaefers HJ; Thorlacius H
Inflamm Res; 2004 Oct; 53(10):523-7. PubMed ID: 15597146
[TBL] [Abstract][Full Text] [Related]
14. Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.
Møller F; Andersen CB; Nielsen LB
Scand J Clin Lab Invest; 2005; 65(7):559-70. PubMed ID: 16271987
[TBL] [Abstract][Full Text] [Related]
15. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
[TBL] [Abstract][Full Text] [Related]
16. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.
Braunersreuther V; Steffens S; Arnaud C; Pelli G; Burger F; Proudfoot A; Mach F
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1090-6. PubMed ID: 18388327
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium.
Sawa Y; Tsuruga E; Iwasawa K; Ishikawa H; Yoshida S
Cell Tissue Res; 2008 Aug; 333(2):237-52. PubMed ID: 18523807
[TBL] [Abstract][Full Text] [Related]
18. Connexin37 protects against atherosclerosis by regulating monocyte adhesion.
Wong CW; Christen T; Roth I; Chadjichristos CE; Derouette JP; Foglia BF; Chanson M; Goodenough DA; Kwak BR
Nat Med; 2006 Aug; 12(8):950-4. PubMed ID: 16862155
[TBL] [Abstract][Full Text] [Related]
19. The transcellular railway: insights into leukocyte diapedesis.
Dejana E
Nat Cell Biol; 2006 Feb; 8(2):105-7. PubMed ID: 16450004
[No Abstract] [Full Text] [Related]
20. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
